Channel protein-containing liposomes as delivery vehicles for the controlled release of drugs-optimization of the lipid composition.
Smisterová
J
J
BioMaDe Technology Foundation, Nijenborgh 4, 9747 AG Groningen, The Netherlands.
van Deemter
M
M
van der Schaaf
G
G
Meijberg
W
W
Robillard
G
G
D002945:Cisplatin / Q000008:administration & dosage; D004337:Drug Carriers; D029968:Escherichia coli Proteins / Q000008:administration & dosage*; D005452:Fluoresceins / Q000008:administration & dosage; D007473:Ion Channels / Q000008:administration & dosage*; D014677:Pharmaceutical Vehicles; D011510:Proteolipids
D004337:Drug Carriers; D029968:Escherichia coli Proteins; D005452:Fluoresceins; D007473:Ion Channels; C086596:MscL protein, E coli; D014677:Pharmaceutical Vehicles; D011510:Proteolipids; C020485:proteoliposomes; D002945:Cisplatin; C007740:fluorexon